The NEXT team at Shulman Rogers is proud to have served as counsel to Adaptive Phage Therapeutics, our long-standing client, in establishing an important collaborative relationship with Mayo Clinic Laboratories to commercialize a phage susceptibility test.
To learn more about this exciting partnership, access the press release here.
Stay up to date with all the latest news and events.
